Health Care Stock Analysis
Page 5 of 6 · 283 articles on Health Care companies
SWI Pick #10 - Veeva Systems (VEEV) - Overcoming Seven Key Risks, A Sleep-Well Investment? [Part 2]
Veeva System ($VEEV) • By Sleep Well Investments • 2023-12-11
Mini deep dive on TransMedics ($TMDX)
TransMedics ($TMDX) • By Large Cap Deep Dives • 2023-12-08
SWI Pick #10 - Veeva Systems (VEEV) - A Leader In Life Science With Seven Critical Risks [Part 1]
Veeva System ($VEEV) • By Sleep Well Investments • 2023-12-08
Cipher Pharmaceuticals - Piclidenoson
Cipher Pharmaceuticals ($CPH) • By Leftfield Investing • 2023-12-05
Business Update - Medistim: Q3-23 Thesis Tracking - No News Is Good News
Medistim ($MEDI) • By Sleep Well Investments • 2023-11-15
✅ Buy Alert - 1st and 2nd sleep-well ownerships - Floor and Decor & Medistim
Medistim ($MEDI) • By Sleep Well Investments • 2023-10-20
Problems at LifeStance Health (LFST)
LifeStance Health ($LFST) • By The Bear Cave • 2023-10-19
Earnings Recap - (SCHW, BAC, & JNJ)
Johnson & Johnson ($JNJ) • By The Investor's Edge • 2023-10-18
Davita (Excerpt From Our Latest Letter)
Davita ($DVA) • By Eagle Point Capital • 2023-10-07
BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on Commercializing Assets in Canada
BioSyent ($RX.V) • By Planet MicroCap • 2023-09-19
Pfizer (NYSE: PFE)
Pfizer ($PFE) • By Quality Value Investing • 2023-09-07
Johnson & Johnson: Odd Lot “Arbitrage” Opportunity
Johnson & Johnson ($JNJ) • By Eagle Point Capital • 2023-08-12
CVS Health (NYSE: CVS)
CVS Health ($CVS) • By Quality Value Investing • 2023-08-10
Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson ($JNJ) • By Quality Value Investing • 2023-08-08
CTX.TO – Crescita Therapeutics: Mediocre Business at an Extraordinary Price with Catalysts
Crescita Therapeutics ($CTX.TO) • By Stephen Frampton • 2023-07-29
Medical Facilities Corp DR.TO - Reitmans 2.0?
Medical Facilities Corp ($DR.TO) • By Stephen Frampton • 2023-07-25
Bayer: The ultimate turnaround
Bayer ($BAYN.DE) • By Modern Investing • 2023-07-17
InMode Stock Analysis & Deep Dive
Inmode ($INMD) • By 41investments • 2023-07-14
AMN Healthcare Services (NYSE: AMN)
AMN Healthcare Services ($AMN) • By Quality Value Investing • 2023-06-20
Immunoprecise Antibodies - AI Meets Biology
Immunoprecise Antibodies ($IPA.V) • By Stephen Frampton • 2023-06-18
Beximco Pharma GDR
Beximco Pharma ($BXP.L) • By Emerging Value • 2023-06-15
Ceapro Inc.: A Moat of Oat
Ceapro Inc. ($CZO.V) • By Stephen Frampton • 2023-05-25
[DHR] Danaher
Danaher ($DHR) • By scuttleblurb • 2023-05-23
Deep Dive #8-2023: AbbVie Inc.
AbbVie ($ABBV) • By The Investor's Edge • 2023-04-30
Portfolio Update: Buying TMF, GOOGL, AMZN. Selling DDOG, MKL, SCHW, LOW, VEEV, GPN
Veeva System ($VEEV) • By Growth Curve Investing • 2023-04-26
Sartorius Polyplus acquisition: An update
Sartorius ($SRT3.DE) • By Heavy Moat Investments • 2023-04-07
Quest Diagnostics: (NYSE: DGX)
Quest Diagnostics ($DGX) • By Quality Value Investing • 2023-03-21
CVS Health (NYSE: CVS)
CVS Health ($CVS) • By Quality Value Investing • 2023-03-14
Eurofins Scientific: Resilient Compounder
Eurofins Scientific ($ERF.PA) • By Eagle Point Capital • 2023-03-11
PHARMANIAGA's (7081.KL) Share Price Fell By -40% Overnight! Is the "Pfizer of Malaysia" About To Go BANKRUPT?
PHARMANIAGA ($7081.KL) • By Value Investing for Professionals • 2023-02-28
UMP Healthcare (722)
UMP Healthcare ($722) • By Asian Century Stocks • 2023-02-26
Fukuda Denshi: Japanese Compounder In The Bargain Bin
Fukuda Denshi ($6960.T) • By Under Valued Japan • 2023-02-09
Lumibird (FR:LBIRD)
Lumibird ($FR:LBIRD) • By Robin Research • 2023-02-06
Deep Dive #1-2023: Johnson & Johnson
Johnson & Johnson ($JNJ) • By The Investor's Edge • 2023-01-12
SDI Group PLC-SDI.L
SDI Group PLC ($SDI.L) • By InvestingWithWes • 2022-12-02
LogicMark, Inc. (NASDAQ: LGMK): From PERS Technology to Caring Platform as a Service [Due Diligence Series]
LogicMark ($LGMK) • By Planet MicroCap • 2022-11-01
TOP GLOVE (BVA.SGX): The Netflix of Gloves & the Cyclical Opportunity of the Next "Industrial Revolution"
TOP GLOVE ($BVA.SGX) • By Value Investing for Professionals • 2022-10-26
Inmode: Betting on Vanity
Inmode ($INMD) • By Value Zoomer • 2022-09-30
Philips Valuation
Philips ($PHIA.AS) • By Enterprising Investor • 2022-09-02
Danaher: A compounding machine over four decades
Danaher ($DHR) • By MBI Deep Dives • 2022-07-21
Embecta (EMBC)
Embecta ($EMBC) • By Johan Lunau • 2022-06-27
VolitionRx (NYSE American: VNRX): Cancer Screening and Diagnostic Tests for Animals and Humans [Due Diligence Podcast]
VolitionRx ($VNRX) • By Planet MicroCap • 2022-05-16
Pro-Dex, Inc. (NASDAQ: PDEX): Designs and Manufactures Medical Devices [Due Diligence Podcast]
Pro-Dex, Inc. ($PDEX) • By Planet MicroCap • 2022-04-11
Japan Lifeline analysis
Japan Lifeline ($7575.T) • By Emerging Value • 2022-04-07
Nephros (NASDAQ: NEPH): Filtration and Pathogen Detection for Medical and Commercial Markets [Due Diligence Podcast]
Nephros ($NEPH) • By Planet MicroCap • 2022-04-04
Watchlist: M1 Kliniken AG (OTC: MKLNF)
M1 Kliniken AG ($M12.DE) • By Small Cap Giants Research • 2022-03-14
Cogstate Ltd. (ASX: CGS) (OTCQX: COGZF): Democratizing Brain Health Assessments [Due Diligence Podcast]
Cogstate Ltd. ($COGZF) • By Planet MicroCap • 2022-03-14
✨ Supermax - the next Hibiscus
Supermax ($7106.KL) • By Value Investing for Professionals • 2022-03-09